← All Mutual Funds

PUTNAM GLOBAL HEALTH CARE FUND

CIK: 0000357295 International
Report date: 2026-04-23
AUM $1.6B
Expense Ratio —
Category International
State MA
Fiscal Year End —
Inception Date —
Manager —
Latest Filing 2026-04-23

About this Fund

PUTNAM GLOBAL HEALTH CARE FUND is a leading mutual fund company that specializes in asset management and investment solutions, catering to a diverse range of investors seeking to grow their wealth through a well-diversified portfolio. With a strong focus on the global healthcare sector, the company offers a unique investment opportunity that leverages the expertise of experienced portfolio managers to identify and capitalize on emerging trends and opportunities in the healthcare industry. The fund's investment portfolio is carefully crafted to include a mix of equity, debt, and hybrid securities, providing investors with a balanced and stable investment strategy that aligns with their risk tolerance and financial goals. By employing a disciplined and research-driven approach to investment, PUTNAM GLOBAL HEALTH CARE FUND is committed to delivering long-term value to its investors, whether they are individual investors, institutional investors, or financial advisors seeking to create customized wealth management solutions for their clients. The company's investor-centric approach is built on a foundation of transparency, trust, and exceptional customer service, ensuring that investors feel confident and supported throughout their investment journey. For investors looking to invest in a systematic and disciplined manner, the company also offers a systematic investment plan (SIP) that enables them to invest a fixed amount of money at regular intervals, providing a convenient and affordable way to build wealth over time. With its strong track record of performance and commitment to excellence in asset management, PUTNAM GLOBAL HEALTH CARE FUND has established itself as a trusted partner for investors seeking to navigate the complexities of the global healthcare industry and achieve their investment objectives. By combining cutting-edge research, rigorous risk management, and a deep understanding of the healthcare sector, the company is well-positioned to deliver superior investment returns and help its investors achieve their financial goals, making it an attractive option for those seeking a reliable and experienced mutual fund company to manage their investment portfolio. Through its dedication to wealth management and investment excellence, PUTNAM GLOBAL HEALTH CARE FUND continues to build long-term relationships with its investors, founded on a shared commitment to achieving financial success and security.

Holdings

From latest SEC N-PORT filing · US-listed stocks only

16 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ABT Abbott Laboratories Since 2026-05-10 002824100 Equity (Common)
0.99%
 $15.81 135,900
2 ABBV AbbVie, Inc. Since 2026-05-10 00287Y109 Equity (Common)
5.94%
 $94.43 406,900
3 ALNY Alnylam Pharmaceuticals, Inc. Since 2026-05-10 02043Q107 Equity (Common)
1.32%
 $20.91 62,800
4 AZN AstraZeneca plc Since 2026-05-10 N/A Equity (Common)
5.04%
 $80.21 381,146
5 CAH Cardinal Health, Inc. Since 2026-05-10 14149Y108 Equity (Common)
2.27%
 $36.08 157,400
6 GILD Gilead Sciences, Inc. Since 2026-05-10 375558103 Equity (Common)
2.68%
 $42.60 286,000
7 ISRG Intuitive Surgical, Inc. Since 2026-05-10 46120E602 Equity (Common)
3.90%
 $61.94 123,020
8 MRK Merck & Co., Inc. Since 2026-05-10 58933Y105 Equity (Common)
5.33%
 $84.78 684,671
9 NVS Novartis AG Since 2026-05-10 N/A Equity (Common)
5.53%
 $87.92 522,868
10 PGEN Precigen, Inc. Since 2026-05-10 74017N105 Equity (Common)
0.22%
 $3.45 910,700
11 REGN Regeneron Pharmaceuticals, Inc. Since 2026-05-10 75886F107 Equity (Common)
1.23%
 $19.56 25,018
12 RYTM Rhythm Pharmaceuticals, Inc. Since 2026-05-10 76243J105 Equity (Common)
0.63%
 $10.00 107,800
13 TMO Thermo Fisher Scientific, Inc. Since 2026-05-10 883556102 Equity (Common)
3.70%
 $58.84 112,920
14 PCVX Vaxcyte, Inc. Since 2026-05-10 92243G108 Equity (Common)
0.89%
 $14.08 228,000
15 NVO Novo Nordisk A/S Since 2026-05-10 N/A Equity (Common)
1.45%
 $23.10 610,832
16 MDT Medtronic plc Since 2026-05-10 N/A Equity (Common)
2.47%
 $39.32 402,600
Frequently Asked Questions — PUTNAM GLOBAL HEALTH CARE FUND
What type of mutual fund is PUTNAM GLOBAL HEALTH CARE FUND?
PUTNAM GLOBAL HEALTH CARE FUND is a SEC-registered International fund, with $1.6B in assets under management. This fund holds a diversified portfolio of securities according to its stated investment mandate as registered with the SEC. As of its latest SEC N-PORT filing, PUTNAM GLOBAL HEALTH CARE FUND holds 16 portfolio positions, all detailed in the holdings table on this page.
What are PUTNAM GLOBAL HEALTH CARE FUND's assets under management (AUM)?
PUTNAM GLOBAL HEALTH CARE FUND has $1.6B in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are PUTNAM GLOBAL HEALTH CARE FUND's top holdings?
According to PUTNAM GLOBAL HEALTH CARE FUND's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include Abbott Laboratories, AbbVie, Inc., Alnylam Pharmaceuticals, Inc. , among others. The complete list of all 16 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is PUTNAM GLOBAL HEALTH CARE FUND's expense ratio?
Expense ratio data for PUTNAM GLOBAL HEALTH CARE FUND is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find PUTNAM GLOBAL HEALTH CARE FUND's SEC filings?
PUTNAM GLOBAL HEALTH CARE FUND is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0000357295. You can access all of PUTNAM GLOBAL HEALTH CARE FUND's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0000357295). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is PUTNAM GLOBAL HEALTH CARE FUND's holdings data on StockSifting?
Holdings data for PUTNAM GLOBAL HEALTH CARE FUND on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.